Literature DB >> 13971779

The contact phase of coagulation in the presence of heparin.

A L BLOOM.   

Abstract

The effect of heparin on the contact phase of coagulation has been investigated by a technique utilizing a solution of toluidine blue in calcium chloride. Heparin in a concentration of 7 units/ml. of plasma does not inhibit contact activation by glass. It is suggested that heparin does not prevent the activation of factor XII (Hageman factor) by glass or the subsequent formation of active factor XI (plasma thromboplastin antecedent).

Entities:  

Keywords:  BLOOD COAGULATION FACTORS; HEPARIN

Mesh:

Substances:

Year:  1962        PMID: 13971779      PMCID: PMC480449          DOI: 10.1136/jcp.15.6.508

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Heparin resistance, thromboplastin generation and glass activation.

Authors:  J GORMSEN
Journal:  Thromb Diath Haemorrh       Date:  1961-07-15

2.  The role of Hageman factor in the initiation of blood coagulation.

Authors:  R M HARDISTY; J MARGOLIS
Journal:  Br J Haematol       Date:  1959-04       Impact factor: 6.998

3.  Initiation of blood coagulation by glass and related surfaces.

Authors:  J MARGOLIS
Journal:  J Physiol       Date:  1957-06-18       Impact factor: 5.182

4.  Heparin and Christmas facfactor.

Authors:  J R O'BRIEN
Journal:  Nature       Date:  1958-06-28       Impact factor: 49.962

5.  The action of thromboplastic substances.

Authors:  R BIGGS; A S DOUGLAS; R G MACFARLANE
Journal:  J Physiol       Date:  1953-12-29       Impact factor: 5.182

6.  The effect of human plasma on the anticoagulant activity of heparin.

Authors:  C L CONLEY; R C HARTMANN; J S LALLEY
Journal:  J Clin Invest       Date:  1950-04       Impact factor: 14.808

  6 in total
  1 in total

1.  Inhibition of Hageman factor activation.

Authors:  H L Nossel; H Rubin; M Drillings; R Hsieh
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.